Search Results - "ANTONY, Kalpana"

Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial by Bhandari, Nita, PhD, Rongsen-Chandola, Temsunaro, MSc, Bavdekar, Ashish, DNB, John, Jacob, MD, Antony, Kalpana, MBA, Taneja, Sunita, PhD, Goyal, Nidhi, DPH, Kawade, Anand, MD, Kang, Gagandeep, Prof, Rathore, Sudeep Singh, MBBS, Juvekar, Sanjay, PhD, Muliyil, Jayaprakash, Prof, Arya, Alok, MPharm, Shaikh, Hanif, MPharm, Abraham, Vinod, MPH, Vrati, Sudhanshu, Prof, Proschan, Michael, PhD, Kohberger, Robert, PhD, Thiry, Georges, PhD, Glass, Roger, PhD, Greenberg, Harry B, Prof, Curlin, George, MD, Mohan, Krishna, PhD, Harshavardhan, G V J A, BVSc, Prasad, Sai, MBA, Rao, T S, PhD, Boslego, John, MD, Bhan, Maharaj Kishan, Dr Prof

“…Summary Background Rotavirus is the most common cause of severe dehydrating gastroenteritis in developing countries. Safe, effective, and affordable rotavirus…”
Get full text

ROTAVAC® does not interfere with the immune response to childhood vaccines in Indian infants: A randomized placebo controlled trial by Chandola, Temsunaro Rongsen, Taneja, Sunita, Goyal, Nidhi, Antony, Kalpana, Bhatia, Kiran, More, Deepak, Bhandari, Nita, Cho, Iksung, Mohan, Krishna, Prasad, Sai, Harshavardhan, GVJA, Rao, Tataji Surender, Vrati, Sudhanshu, Bhan, Maharaj Kishan

“…A phase III randomized double-blind placebo-controlled trial was conducted in the urban neighborhoods of Delhi to assess whether Oral Rotavirus Vaccine…”
Get full text

Diarrheal Etiology and Impact of Coinfections on Rotavirus Vaccine Efficacy Estimates in a Clinical Trial of a Monovalent Human-Bovine (116E) Oral Rotavirus Vaccine, Rotavac, India by Praharaj, Ira, Platts-Mills, James A, Taneja, Sunita, Antony, Kalpana, Yuhas, Krista, Flores, Jorge, Cho, Iksung, Bhandari, Nita, Revathy, R, Bavdekar, Ashish, Rongsen-Chandola, Temsunaro, McMurry, Timothy, Houpt, Eric R, Kang, Gagandeep

“…Rotavirus vaccine efficacy (VE) estimates in low-resource settings are lower than in developed countries. We detected coinfections in cases of severe rotavirus…”
Get full text

Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial by Clarke, Ed, Bashorun, Adedapo, Adigweme, Ikechukwu, Badjie Hydara, Mariama, Umesi, Ama, Futa, Ahmed, Ochoge, Magnus, Obayemi, Dolapo, Edem, Bassey, Saidy-Jah, Ebrima, Onwuchekwa, Chukwuemeka, Dhere, Rajeev, Sethna, Vistasp, Kampmann, Beate, Goldblatt, David, Taylor, Douglas, Andi-Lolo, Indah, Hosken, Nancy, Antony, Kalpana, Innis, Bruce L, Alderson, Mark R, Lamola, Steve

“…An affordable pneumococcal conjugate vaccine (PCV) is needed to ensure sustainable access in low-income and middle-income countries. This trial examined the…”
Get full text

Safety and immunogenicity of Innovax bivalent human papillomavirus vaccine in girls 9–14 years of age: Interim analysis from a phase 3 clinical trial by Zaman, Khalequ, Schuind, Anne E, Adjei, Samuel, Antony, Kalpana, Aponte, John J, Buabeng, Patrick BY, Qadri, Firdausi, Kemp, Troy J, Hossain, Lokman, Pinto, Ligia A, Sukraw, Kristen, Bhat, Niranjan, Agbenyega, Tsiri

“…•Innovax bivalent HPV vaccine (Cecolin), and Gardasil have similar safety profiles.•Two Cecolin doses six months apart are immunologically non-inferior to…”
Get full text

Immunogenicity and safety of a 10-valent pneumococcal conjugate vaccine administered as a 2 + 1 schedule to healthy infants in The Gambia: a single-centre, double-blind, active-controlled, randomised, phase 3 trial by Adigweme, Ikechukwu, Futa, Ahmed, Saidy-Jah, Ebrima, Edem, Bassey, Akpalu, Edem, Dibbasey, Tida, Sethna, Vistasp, Dhere, Rajeev, Kampmann, Beate, Bengt, Christopher, Sirr, Jake, Hosken, Nancy, Goldblatt, David, Antony, Kalpana, Alderson, Mark R, Lamola, Steve, Clarke, Ed

“…Three pneumococcal conjugate vaccines (PCVs) are currently licensed and WHO prequalified for supply by UN agencies. Here, we aimed to investigate the safety…”
Get full text

Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life by Bhandari, Nita, Rongsen-Chandola, Temsunaro, Bavdekar, Ashish, John, Jacob, Antony, Kalpana, Taneja, Sunita, Goyal, Nidhi, Kawade, Anand, Kang, Gagandeep, Rathore, Sudeep Singh, Juvekar, Sanjay, Muliyil, Jayaprakash, Arya, Alok, Shaikh, Hanif, Abraham, Vinod, Vrati, Sudhanshu, Proschan, Michael, Kohberger, Robert, Thiry, Georges, Glass, Roger, Greenberg, Harry B, Curlin, George, Mohan, Krishna, Harshavardhan, G.V.J.A, Prasad, Sai, Rao, T.S, Boslego, John, Bhan, Maharaj Kishan

“…Highlights • Efficacy of 116E against severe RVGE sustained in the second year of life. • Protection of 116E increased with greater severity of RV associated…”
Get full text

Active surveillance for intussusception in a phase III efficacy trial of an oral monovalent rotavirus vaccine in India by John, Jacob, Kawade, Anand, Rongsen-Chandola, Temsunaro, Bavdekar, Ashish, Bhandari, Nita, Taneja, Sunita, Antony, Kalpana, Bhatnagar, Veereshwar, Gupta, Arun, Kabra, Madhulika, Kang, Gagandeep

“…Highlights • Active surveillance for intussusception was conducted with follow up to 2 years of age in 6799 trial participants. • Twenty-three cases had an…”
Get full text

Assessment of risk of intussusception after pilot rollout of rotavirus vaccine in the Indian public health system by Bhandari, Nita, Antony, Kalpana, Balraj, Vinohar, Rongsen-Chandola, Temsunaro, Kumar, Tivendra, Sinha, Bireshwar, Goyal, Nidhi, Guleri, Rajesh, Bavdekar, Ashish, Juvekar, Sanjay, Dayma, Girish, Patwardhan, Vaijayanti, Patil, Archana, Kang, Gagandeep, Mohan, Venkata Raghava, Srinivasan, Rajan, Naaraayan, Sridevi A., Reddy, Samarasimha, Bhan, Maharaj Kishan, Rao, Tataji Surender, Parashar, Umesh, Muliyil, Jaya Prakash, Tate, Jaqueline, Andrews, Nicholas J., Samuel, Prasanna, Ganesan, Santhosh Kumar, Taneja, Sunita, Choudhary, Tarun Shankar, Bhatnagar, Veereshwar, Gupta, Arun Kumar, Kabra, Madhulika

“…•Prelicensure trials of ROTAVAC® not powered to assess risk of intussusception.•During ROTAVAC®rollout we assessed risk of intussusception in infants in 3…”
Get full text

A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants by Rathi, Niraj, Desai, Sajjad, Kawade, Anand, Venkatramanan, Padmasani, Kundu, Ritabrata, Lalwani, Sanjay K., Dubey, A.P., Venkateswara Rao, J., Narayanappa, D., Ghildiyal, Radha, Gogtay, Nithya, Venugopal, P., Palkar, Sonali, Munshi, Renuka, Kang, Gagandeep, Babji, Sudhir, Bavdekar, Ashish, Juvekar, Sanjay, Ganguly, Nupur, Niyogi, Prabal, Ghosh Uttam, Kheya, Rajani, H.S., Kondekar, Alpana, Kumbhar, Dipti, Mohanlal, Smilu, Agarwal, Mukesh C, Shetty, Parvan, Antony, Kalpana, Gunale, Bhagwat, Dharmadhikari, Abhijeet, Tang, Yuxiao, Kulkarni, Prasad S., Flores, Jorge

“…•Pentavalent reassortant rotavirus vaccine (BRV-PV) was tested for lot-to-lot consistency in Indian infants.•The vaccine demonstrated safety profile similar to…”
Get full text

Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL® with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine by Desai, Sajjad, Rathi, Niraj, Kawade, Anand, Venkatramanan, Padmasani, Kundu, Ritabrata, Lalwani, Sanjay K., Dubey, A.P., Venkateswara Rao, J., Narayanappa, D., Ghildiyal, Radha, Gogtay, Nithya J, Venugopal, P., Palkar, Sonali, Munshi, Renuka, Bavdekar, Ashish, Juvekar, Sanjay, Ganguly, Nupur, Niyogi, Prabal, Uttam, Kheya Ghosh, Kondekar, Alpana, Kumbhar, Dipti, Mohanlal, Smilu, Agarwal, Mukesh C., Shetty, Parvan, Antony, Kalpana, Gunale, Bhagwat, Dharmadhikari, Abhijeet, Deshpande, Jagdish, Nalavade, Uma, Sharma, Deepa, Bansal, Anurag, Tang, Yuxiao, Flores, Jorge, Kulkarni, Prasad S.

“…A newly developed bovine-human reassortant pentavalent vaccine (BRV-PV, ROTASIIL®) was tested for its potential effect on the immunogenicity of concomitantly…”
Get full text

Response to: Letter from P. Gillard and B. Benninghoff by Rathi, Niraj, Desai, Sajjad, Kawade, Anand, Venkatramanan, Padmasani, Kundu, Ritabrata, Lalwani, Sanjay K., Dubey, A.P., Venkateswara Rao, J., Narayanappa, D., Ghildiyal, Radha, Gogtay, Nithya J., Venugopal, P., Palkar, Sonali, Munshi, Renuka, Kang, Gagandeep, Babji, Sudhir, Bavdekar, Ashish, Juvekar, Sanjay, Ganguly, Nupur, Niyogi, Prabal, Uttam, Kheya Ghosh, Rajani, H.S., Kondekar, Alpana, Kumbhar, Dipti, Mohanlal, Smilu, Agarwal, Mukesh C., Shetty, Parvan, Antony, Kalpana, Gunale, Bhagwat, Dharmadhikari, Abhijeet, Tang, Yuxiao, Kulkarni, Prasad S., Flores, Jorge

Get full text

Active surveillance for intussusception in a phase III efficacy trial of an oral monovalent rotavirus vaccine in India: Rotavirus in India: An update on epidemiology and vaccines by JOHN, Jacob, KAWADE, Anand, KANG, Gagandeep, RONGSEN-CHANDOLA, Temsunaro, BAVDEKAR, Ashish, BHANDARI, Nita, TANEJA, Sunita, ANTONY, Kalpana, BHATNAGAR, Veereshwar, GUPTA, Arun, KABRA, Madhulika

Get full text

Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life: Rotavirus in India: An update on epidemiology and vaccines by BHANDARI, Nita, RONGSEN-CHANDOLA, Temsunaro, JUVEKAR, Sanjay, MULIYIL, Jayaprakash, ARYA, Alok, SHAIKH, Hanif, ABRAHAM, Vinod, VRATI, Sudhanshu, PROSCHAN, Michael, KOHBERGER, Robert, THIRY, Georges, GLASS, Roger, BAVDEKAR, Ashish, GREENBERG, Harry B, CURLIN, George, MOHAN, Krishna, HARSHAVARDHAN, G. V. J. A, PRASAD, Sai, RAO, T. S, BOSLEGO, John, MAHARAJ KISHAN BHAN, JOHN, Jacob, ANTONY, Kalpana, TANEJA, Sunita, GOYAL, Nidhi, KAWADE, Anand, KANG, Gagandeep, SUDEEP SINGH RATHORE

Get full text